Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Anti-inflammatory therapeutics are drugs used to treat inflammation that occurs after tissues are injured. There are two types of anti-inflammatory therapeutics: one is steroidal anti-inflammatory therapeutics, and the other is non-steroidal anti-inflammatory therapeutics, which are antipyretic and analgesic anti-inflammatory therapeutics referred to in medical practice, such as aspirin.
There are many inflammations that have not yet found a suitable diagnosis and treatment method. The intake of anti-inflammatory therapeutics can greatly reduce the pain caused by inflammation, and the cost is less than that of surgery. However, taking anti-inflammatory therapeutics will bring certain side effects, which hinders the development of the market to a certain extent.
The increasing incidence of chronic inflammation and autoimmune diseases has increased the demand for anti-inflammatory therapeutics. In addition, it is expected that the increasing awareness of anti-inflammatory therapeutics and the active measures of governments in the Asia-Pacific region will drive market growth. The research and development of new anti-inflammatory therapeutics by major developers in the market provides opportunities for the development of the anti-inflammatory therapeutics market.
The report details the trend, potential and market size of Anti-inflammatory Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Anti-inflammatory Therapeuticsmarket, defines the market attractiveness level of Anti-inflammatory Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Anti-inflammatory Therapeutics industry, describes the types of Anti-inflammatory Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anti-inflammatory Therapeutics market and the development prospects and opportunities of Anti-inflammatory Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anti-inflammatory Therapeutics market in Chapter 13.
By Player:
Eli Lily and Company
AstraZeneca PLC
Amgen Inc
Novartis AG
Johnson & Johnson
GlaxoSmithKline plc
By Type:
Nonsteroidal Anti-inflammatory Diseases (NSAIDs)
Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
Corticosteroids
Biologics
Other
By End-User:
Arthritis
Psoriasis
Respiratory Disease
Multiple Sclerosis
Inflammatory Bowel Disease
Other Inflammatory Disease
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Anti-inflammatory Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Anti-inflammatory Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Anti-inflammatory Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Anti-inflammatory Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Anti-inflammatory Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Anti-inflammatory Therapeutics Consumption (2017-2022)
-
7.2 United States Anti-inflammatory Therapeutics Consumption (2017-2022)
-
7.3 Europe Anti-inflammatory Therapeutics Consumption (2017-2022)
-
7.4 China Anti-inflammatory Therapeutics Consumption (2017-2022)
-
7.5 Japan Anti-inflammatory Therapeutics Consumption (2017-2022)
-
7.6 India Anti-inflammatory Therapeutics Consumption (2017-2022)
-
7.7 South Korea Anti-inflammatory Therapeutics Consumption (2017-2022)
8 Region and Country-wise Anti-inflammatory Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Anti-inflammatory Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Anti-inflammatory Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Anti-inflammatory Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Anti-inflammatory Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Anti-inflammatory Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Anti-inflammatory Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Anti-inflammatory Therapeutics Consumption Forecast (2022-2028)
9 Global Anti-inflammatory Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Anti-inflammatory Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Nonsteroidal Anti-inflammatory Diseases (NSAIDs) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Immune Selective Anti-inflammatory Derivatives (ImSAIDs) Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Biologics Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Anti-inflammatory Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Arthritis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Psoriasis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Respiratory Disease Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Multiple Sclerosis Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Inflammatory Bowel Disease Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Other Inflammatory Disease Consumption and Growth Rate (2017-2022)
10 Global Anti-inflammatory Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Anti-inflammatory Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Nonsteroidal Anti-inflammatory Diseases (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Immune Selective Anti-inflammatory Derivatives (ImSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Biologics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Anti-inflammatory Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Psoriasis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Respiratory Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Inflammatory Bowel Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Other Inflammatory Disease Consumption Forecast and Growth Rate (2022-2028)
11 Global Anti-inflammatory Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Anti-inflammatory Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Anti-inflammatory Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Anti-inflammatory Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Anti-inflammatory Therapeutics Market Competitive Analysis
-
14.1 Eli Lily and Company
-
14.1.1 Eli Lily and Company Company Details
-
14.1.2 Eli Lily and Company Anti-inflammatory Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Eli Lily and Company Anti-inflammatory Therapeutics Product and Service
-
14.2 AstraZeneca PLC
-
14.2.1 AstraZeneca PLC Company Details
-
14.2.2 AstraZeneca PLC Anti-inflammatory Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 AstraZeneca PLC Anti-inflammatory Therapeutics Product and Service
-
14.3 Amgen Inc
-
14.3.1 Amgen Inc Company Details
-
14.3.2 Amgen Inc Anti-inflammatory Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Amgen Inc Anti-inflammatory Therapeutics Product and Service
-
14.4 Novartis AG
-
14.4.1 Novartis AG Company Details
-
14.4.2 Novartis AG Anti-inflammatory Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novartis AG Anti-inflammatory Therapeutics Product and Service
-
14.5 Johnson & Johnson
-
14.5.1 Johnson & Johnson Company Details
-
14.5.2 Johnson & Johnson Anti-inflammatory Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Johnson & Johnson Anti-inflammatory Therapeutics Product and Service
-
14.6 GlaxoSmithKline plc
-
14.6.1 GlaxoSmithKline plc Company Details
-
14.6.2 GlaxoSmithKline plc Anti-inflammatory Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 GlaxoSmithKline plc Anti-inflammatory Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Anti-inflammatory Therapeutics
-
Figure Anti-inflammatory Therapeutics Picture
-
Table Global Anti-inflammatory Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-inflammatory Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-inflammatory Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Anti-inflammatory Therapeutics Consumption by Country (2017-2022)
-
Figure United States Anti-inflammatory Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Anti-inflammatory Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Anti-inflammatory Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Anti-inflammatory Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Anti-inflammatory Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Anti-inflammatory Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-inflammatory Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Anti-inflammatory Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Anti-inflammatory Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Anti-inflammatory Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Anti-inflammatory Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Anti-inflammatory Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Anti-inflammatory Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nonsteroidal Anti-inflammatory Diseases (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Global Immune Selective Anti-inflammatory Derivatives (ImSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
Figure Global Biologics Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Psoriasis Consumption and Growth Rate (2017-2022)
-
Figure Global Respiratory Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Multiple Sclerosis Consumption and Growth Rate (2017-2022)
-
Figure Global Inflammatory Bowel Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Other Inflammatory Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Nonsteroidal Anti-inflammatory Diseases (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immune Selective Anti-inflammatory Derivatives (ImSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biologics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Psoriasis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Respiratory Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Inflammatory Bowel Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Inflammatory Disease Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Anti-inflammatory Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Anti-inflammatory Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Eli Lily and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lily and Company Anti-inflammatory Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lily and Company Anti-inflammatory Therapeutics Product and Service
-
Table AstraZeneca PLC (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca PLC Anti-inflammatory Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca PLC Anti-inflammatory Therapeutics Product and Service
-
Table Amgen Inc (Foundation Year, Company Profile and etc.)
-
Table Amgen Inc Anti-inflammatory Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Inc Anti-inflammatory Therapeutics Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Anti-inflammatory Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Anti-inflammatory Therapeutics Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Anti-inflammatory Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Anti-inflammatory Therapeutics Product and Service
-
Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline plc Anti-inflammatory Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Anti-inflammatory Therapeutics Product and Service
-
